Are Selective Serotonin Reuptake Inhibitors (SSRIs) associated with jaw clenching?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SSRIs Are Clearly Associated with Jaw Clenching and Bruxism

Yes, SSRIs are definitively associated with jaw clenching (bruxism), typically developing within 2-4 weeks of treatment initiation or dose increases. 1 This is a recognized adverse effect across the SSRI class, though individual agents may vary in their propensity to cause this side effect.

Mechanism and Clinical Presentation

  • The mechanism involves serotonergic effects on motor control, likely through increased serotonin availability affecting dopaminergic pathways that regulate jaw muscle tone 2
  • Bruxism typically manifests as nocturnal tooth clenching and/or grinding during sleep, though daytime jaw clenching can also occur 1
  • Onset is usually within 2-4 weeks after starting an SSRI or increasing the dose 1
  • Both fluoxetine and sertraline have been specifically documented to cause this adverse effect 1, 3

Specific SSRIs Implicated

  • Fluoxetine (the most activating SSRI) has been associated with bruxism development 4, 1
  • Sertraline has been documented to cause both mandibular dystonia and bruxism, even in the absence of other dopaminergic medications 3
  • Paroxetine, while less activating, can still cause this adverse effect 4

Management Strategies

When SSRI-associated bruxism occurs, you have three evidence-based options:

Option 1: Dose Reduction

  • Decreasing the SSRI dosage successfully resolved bruxism in documented cases 1
  • This approach is appropriate if the patient's depression is adequately controlled at a lower dose

Option 2: Add Buspirone

  • Adding buspirone (a 5-HT1A partial agonist) relieved SSRI-associated bruxism in multiple patients 1
  • Buspirone is currently considered one of the most effective medications to treat SSRI-induced bruxism 2
  • This allows continuation of the effective SSRI dose while managing the side effect

Option 3: Add Low-Dose Quetiapine

  • Low-dose quetiapine (25-50 mg daily) successfully treated SSRI-induced bruxism in case series 5
  • The mechanism involves quetiapine's 5-HT2 receptor antagonism, which counteracts the serotonergic effects causing bruxism 5
  • Improvement typically occurs within a few days of starting quetiapine 5

Clinical Implications for Temporomandibular Joint Disorder (TMD)

  • SSRIs may not be suitable first-line antidepressants for patients with pre-existing TMD or bruxism, as SSRI-induced bruxism can exacerbate TMD 2
  • Consider alternative antidepressant classes in these patients, including SNRIs, tricyclic antidepressants, or atypical antidepressants, though evidence for specific alternatives remains inconclusive 2

Important Caveats

  • This is a class effect of SSRIs, not limited to specific agents, though individual susceptibility varies 2, 1
  • Patients may not spontaneously report jaw clenching, so direct questioning about teeth grinding, jaw pain, or dental damage is necessary during follow-up
  • Dental examination may reveal evidence of bruxism (tooth wear, jaw muscle tenderness) even when patients are unaware of the behavior 1
  • The adverse effect is reversible with dose reduction or adjunctive treatment 1

References

Research

SSRI-associated nocturnal bruxism in four patients.

The Journal of clinical psychiatry, 1993

Research

Sertraline induced mandibular dystonia and bruxism.

Journal of family medicine and primary care, 2016

Guideline

Activating Effects of SSRIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.